James V. Heck

2.1k total citations
30 papers, 1.6k citations indexed

About

James V. Heck is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, James V. Heck has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in James V. Heck's work include Synthesis of β-Lactam Compounds (8 papers), Peroxisome Proliferator-Activated Receptors (7 papers) and Microbial Natural Products and Biosynthesis (5 papers). James V. Heck is often cited by papers focused on Synthesis of β-Lactam Compounds (8 papers), Peroxisome Proliferator-Activated Receptors (7 papers) and Microbial Natural Products and Biosynthesis (5 papers). James V. Heck collaborates with scholars based in United States, Sweden and Spain. James V. Heck's co-authors include David E. Moller, Scott D. Feighner, Karen K. McKee, Andrew D. Howard, Vivien A. Warren, Maria A. Bednarek, Maria V. Silva, Sheng‐Shung Pong, Donna L. Hreniuk and B. G. CHRISTENSEN and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

James V. Heck

28 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James V. Heck United States 19 614 483 432 358 335 30 1.6k
James R. Tata United States 21 637 1.0× 606 1.3× 249 0.6× 152 0.4× 164 0.5× 62 1.7k
Christopher Fotsch United States 25 806 1.3× 931 1.9× 121 0.3× 157 0.4× 146 0.4× 48 1.8k
Gino Salituro United States 20 803 1.3× 392 0.8× 111 0.3× 72 0.2× 147 0.4× 46 1.6k
Hiskias G. Keizer Netherlands 16 631 1.0× 294 0.6× 27 0.1× 290 0.8× 116 0.3× 27 1.9k
G. Arvidson Sweden 13 702 1.1× 128 0.3× 44 0.1× 284 0.8× 163 0.5× 25 1.4k
A. Müller Germany 16 464 0.8× 446 0.9× 22 0.1× 381 1.1× 157 0.5× 34 1.5k
Simona Bertoni Italy 25 739 1.2× 316 0.7× 56 0.1× 57 0.2× 177 0.5× 77 1.6k
Carmen Diniz Portugal 18 470 0.8× 265 0.5× 46 0.1× 65 0.2× 126 0.4× 63 1.4k
Liangwei Zhong China 20 1.7k 2.7× 252 0.5× 29 0.1× 703 2.0× 169 0.5× 31 2.2k
M. Delaforge France 20 401 0.7× 100 0.2× 51 0.1× 52 0.1× 417 1.2× 55 1.4k

Countries citing papers authored by James V. Heck

Since Specialization
Citations

This map shows the geographic impact of James V. Heck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James V. Heck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James V. Heck more than expected).

Fields of papers citing papers by James V. Heck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James V. Heck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James V. Heck. The network helps show where James V. Heck may publish in the future.

Co-authorship network of co-authors of James V. Heck

This figure shows the co-authorship network connecting the top 25 collaborators of James V. Heck. A scholar is included among the top collaborators of James V. Heck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James V. Heck. James V. Heck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Cuihua, Sofía Barluenga, Girish Koripelly, et al.. (2009). Synthesis of pochoxime prodrugs as potent HSP90 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(14). 3836–3840. 15 indexed citations
2.
Desai, Ranjit C., E. Joseph Metzger, Conrad Santini, et al.. (2005). Design and synthesis of potent and subtype-selective PPARα agonists. Bioorganic & Medicinal Chemistry Letters. 16(6). 1673–1678. 17 indexed citations
3.
Dropinski, James F., Yong Zhang, Conrad Santini, et al.. (2005). Novel 2,3-Dihydrobenzofuran-2-carboxylic Acids:  Highly Potent and Subtype-Selective PPARα Agonists with Potent Hypolipidemic Activity. Journal of Medicinal Chemistry. 48(17). 5589–5599. 87 indexed citations
4.
Desai, Ranjit C., Hiroo Koyama, E. Joseph Metzger, et al.. (2003). Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists. Bioorganic & Medicinal Chemistry Letters. 13(20). 3541–3544. 18 indexed citations
5.
Desai, Ranjit C., E. Joseph Metzger, Karen L. MacNaul, et al.. (2003). 5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents. Bioorganic & Medicinal Chemistry Letters. 13(16). 2795–2798. 42 indexed citations
6.
Koyama, Hiroo, E. Joseph Metzger, Daniel J. Miller, et al.. (2003). 5-Aryl thiazolidine-2,4-diones as selective PPARγ agonists. Bioorganic & Medicinal Chemistry Letters. 13(10). 1801–1804. 34 indexed citations
7.
Qureshi, Sajjad A., Victor Ding, Zhihua Li, et al.. (2000). Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators. Journal of Biological Chemistry. 275(47). 36590–36595. 56 indexed citations
8.
Liu, Kun, Libo Xu, Deborah Szalkowski, et al.. (2000). Discovery of a Potent, Highly Selective, and Orally Efficacious Small-Molecule Activator of the Insulin Receptor. Journal of Medicinal Chemistry. 43(19). 3487–3494. 74 indexed citations
9.
Wilkening, Robert R., Ronald W. Ratcliffe, Kenneth J. Wildonger, et al.. (1999). Synthesis and activity of 2-(sulfonamido)methyl-carbapenems: Discovery of a novel, anti-MRSA 1,8-naphthosultam pharmacophore. Bioorganic & Medicinal Chemistry Letters. 9(5). 673–678. 21 indexed citations
10.
Ratcliffe, Ronald W., Robert R. Wilkening, Kenneth J. Wildonger, et al.. (1999). Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: Discovery of L-786,392. Bioorganic & Medicinal Chemistry Letters. 9(5). 679–684. 22 indexed citations
11.
Zhang, Bei, Gino Salituro, Deborah Szalkowski, et al.. (1999). Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice. Science. 284(5416). 974–977. 336 indexed citations
12.
Jayasuriya, Hiranthi, Gino Salituro, Scott K. Smith, et al.. (1998). Complestatin to chloropeptin I via a quantitative acid catalyzed rearrangement. Absolute stereochemical determination of complestatin.. Tetrahedron Letters. 39(16). 2247–2248. 27 indexed citations
13.
14.
Zambias, Robert A., Milton L. Hammond, James V. Heck, et al.. (1992). Preparation and structure-activity relationships of simplified analogs of the antifungal agent cilofungin: a total synthesis approach. Journal of Medicinal Chemistry. 35(15). 2843–2855. 46 indexed citations
15.
Szymonifka, Michael J. & James V. Heck. (1989). The preparation and alkylation of β-sultam mono- and dianions. Tetrahedron Letters. 30(22). 2873–2876. 4 indexed citations
16.
Szymonifka, Michael J. & James V. Heck. (1989). The synthesis and reactions of 4-carbomethoxy β-sultams. Tetrahedron Letters. 30(22). 2869–2872. 29 indexed citations
17.
Chang, Michael N., et al.. (1988). Absolute configuration of L659,699, a novel inhibitor of cholesterol biosynthesis. The Journal of Organic Chemistry. 53(19). 4599–4603. 18 indexed citations
18.
19.
Andrus, Alex, B. G. CHRISTENSEN, & James V. Heck. (1984). Synthesis of 3-methylphosphonyl thienamycin and related 3-phosphonyl carbapenems. Tetrahedron Letters. 25(6). 595–598. 15 indexed citations
20.
Andrus, Alex, et al.. (1984). The synthesis of N-(tetrazol-5-yl)azetidin-2-ones. Tetrahedron Letters. 25(9). 911–914. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James R. Tata Breakdown of academic impact, for papers by Christopher Fotsch Breakdown of academic impact, for papers by Gino Salituro Breakdown of academic impact, for papers by Hiskias G. Keizer Breakdown of academic impact, for papers by G. Arvidson Breakdown of academic impact, for papers by A. Müller Breakdown of academic impact, for papers by Simona Bertoni Breakdown of academic impact, for papers by Carmen Diniz Breakdown of academic impact, for papers by Liangwei Zhong Breakdown of academic impact, for papers by M. Delaforge
Rankless by CCL
2026